Cystic renal-epithelial derived induced pluripotent stem cells from polycystic kidney disease patients

Annegien T Kenter1,2,3, Eveline Rentmeester1, Job van Riet4

  • 1Department of Developmental Biology, Erasmus Medical Center Rotterdam (EMC), Oncode Institute, Rotterdam, The Netherlands.

Insights

Autosomal-dominant polycystic kidney disease (ADPKD) research advances with patient-specific induced pluripotent stem cells (iPSCs). These iPSCs model PKD1 gene function in kidney cyst formation, offering new insights into disease mechanisms.

Area of Science:

  • Nephrology
  • Genetics
  • Stem Cell Biology

Background:

  • Autosomal-dominant polycystic kidney disease (ADPKD) is the most prevalent inherited kidney disorder, frequently resulting in kidney failure.
  • Mutations in the PKD1 gene account for approximately 85% of ADPKD cases, yet the molecular mechanisms of cystogenesis remain unclear.
  • Induced pluripotent stem cells (iPSCs) offer a valuable platform for in vitro modeling of genetic kidney diseases.

Purpose of the Study:

  • To establish and characterize ADPKD patient-specific iPSCs for studying PKD1 function in kidney development and cyst formation.
  • To investigate the role of somatic mutations and DNA methylation in ADPKD pathogenesis using iPSCs derived from renal epithelial cells.

Main Methods:

  • Generation of iPSCs from ADPKD patient-derived cystic renal epithelial cells and healthy controls.
  • Comprehensive mutation analysis of PKD1, PKD2, and other ADPKD-associated genes in iPSCs.
  • Whole-genome DNA methylation analysis to assess kidney-specific epigenetic memory and disease-associated alterations.

Main Results:

  • ADPKD patient-specific iPSCs were successfully generated, harboring germline PKD1 mutations but lacking additional somatic mutations in PKD1/PKD2.
  • Analysis revealed a heterogeneous mutational landscape in the original cystic cells, with limited carryover of somatic mutations into iPSCs.
  • iPSCs derived from renal epithelial cells retained kidney-specific DNA methylation patterns, with distinct methylation differences observed in PKD1+/- iPSCs compared to controls.

Conclusions:

  • Generated and characterized ADPKD patient-specific iPSCs provide a robust in vitro model for studying kidney development and cystogenesis.
  • These iPSCs can be utilized to investigate the molecular mechanisms underlying PKD1 dysregulation in ADPKD.
  • The findings highlight the potential of iPSCs in understanding inherited kidney diseases and exploring therapeutic strategies.

Related Concept Videos

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.2K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.1K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.9K